EP. 18: Implications for Using FGFR Inhibitors in Advanced CCA
April 19th 2021
Milind Javle, MD, of The University of Texas MD Anderson Cancer Center, explains what GI oncologists can expect from FGFR treatment for advanced cholangiocarcinoma in terms of treatment responses.